Form 8-K - Current report:
SEC Accession No. 0001628280-24-001805
Filing Date
2024-01-22
Accepted
2024-01-19 18:08:57
Documents
12
Period of Report
2024-01-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arwr-20240116.htm   iXBRL 8-K 28225
  Complete submission text file 0001628280-24-001805.txt   157459

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arwr-20240116.xsd EX-101.SCH 1931
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arwr-20240116_lab.xml EX-101.LAB 24851
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arwr-20240116_pre.xml EX-101.PRE 13066
6 EXTRACTED XBRL INSTANCE DOCUMENT arwr-20240116_htm.xml XML 2829
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 24546644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)